Evaluation of Tolerability and Safety of “Allergovac Poliplus” in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Conditions:   Allergic Rhinitis;   Rhinoconjunctivitis;   AsthmaIntervention:   Biological: Allergovac PoliplusSponsor:   BIAL Industrial Farmacéutica S.A.Not yet recruiting – verified July 2016 View full post on asthma | Studies received in the last 14 days

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men

Conditions:   Asthma;   Chronic Obstructive Pulmonary Disease (COPD)Interventions:   Drug: AZD7594 inhalation powder (200 ?g);   Drug: AZD7594 inhalation powder (400 ?g);   Drug: AZD7594 pressurized inhalation suspension (200 ?g);   Drug: AZD7594 placebo inhalation powder;   Drug: AZD7594 placebo pressurized inhalation suspensionSponsor:   AstraZenecaNot yet recruiting – verified December 2015 View full post on asthma…

Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

Conditions:   Asthma (Part 1);   COPD (Part 2)Interventions:   Drug: Dose 1, AZD8871 50 ?g (Part 1);   Drug: Dose 2, AZD8871 100 ?g (Part 1);   Drug: Dose 3, AZD8871 300 ?g (Part 1);   Drug: Dose 4, AZD8871 600 µg (Part 1);   Drug: Dose 5, AZD8871 1200 µg (Part 1);   Drug: Dose 6, AZD8871 1800 ?g (Part 1);   Drug: Placebo, AZD8871 placebo (Part 1);   Drug: Treatment A, AZD8871 dose A (Part 2);   Drug: Treatment B, AZD8871 dose B (Part 2);   Drug: Treatment C, Indacaterol 150 ?g (Part 2);   Drug: Treatment D, Tiotropium 18 ?g (Part 2)Sponsor:   AstraZenecaNot yet recruiting – verified October 2015 View full post on…

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

Condition:   AsthmaInterventions:   Drug: Treatment A: Fp MDPI;   Drug: Treatment B: FS MDPI;   Drug: Treatment C Flovent;   Drug: Treatment D:  AdvairSponsor:   Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified May 2015 View full post on asthma | received in the last 14 days

Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma

Conditions:   Rhinitis;   Rhinoconjunctivitis;   AsthmaInterventions:   Biological: DP/MG/14-1;   Biological: DP/MG/14-2Sponsor:   Laboratorios Leti, S.L.Recruiting – verified January 2015 View full post on asthma | received in the last 14 days

A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

Condition:   AsthmaInterventions:   Drug: NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler;   Drug: SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler;   Drug: NEUMOTEX 400 (Budesonide 400 mcg);   Drug: Salbutamol 100 mcg pMDISponsors:   GlaxoSmithKline;   Laboratorios PhoenixNot yet recruiting – verified September 2014 View full post on…

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses” in Healthy Volunteers.

Condition:   AsthmaInterventions:   Drug: PBF-680;   Drug: PlaceboSponsors:   Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau;   Palo Biofarma, S.LRecruiting – verified August 2014 View full post on asthma | received in the last 14 days

Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Chronic Asthma

Condition:   AsthmaIntervention:   Drug: Laninamivir octanoateSponsors:   Biota Scientific Management Pty Ltd;   Department of Health and Human ServicesRecruiting – verified December 2013 View full post on asthma | received in the last 14 days